Skip to main content
. 2010 Jun 25;5(6):e11277. doi: 10.1371/journal.pone.0011277

Figure 1. Flow diagram of study design.

Figure 1

Participants were screened from −28 to −3 days before inclusion. The injections were given at day 0 and day 42 or on day 0 and day 84. Group A and B received 0.01 µg of the investigational skin test antigen. Group C and D received 0.1 µg. All volunteers completed a final follow-up visit 28 days after the last injection.